Metagenomic Analysis Reveals the Heterogeneity of Conjunctival Microbiota Dysbiosis in Dry Eye Disease
-
Quality control
- Retracted paper
- Contamination issues suspected
- Batch effect issues suspected
- Uncontrolled confounding suspected
- Results are suspect (various reasons)
- Tags applied
Experiment 1
Subjects
- Location of subjects
- China
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Bulbar conjunctiva Ocular conjunctiva,Bulbar conjunctiva,bulbar conjunctiva
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Biological sex Biological sex,biological sex
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- female patients with dry eye disease
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- male patients with dry eye disease
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- male patients with dry eye disease
- Group 0 sample size Number of subjects in the control (unexposed) group
- 22
- Group 1 sample size Number of subjects in the case (exposed) group
- 25
- Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
- 90 days prior to enrollment
Lab analysis
- Sequencing type
- WMS
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- Not specified
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- relative abundances
- Statistical test
- Linear Regression
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- Confounders controlled for Confounding factors that have been accounted for by stratification or model adjustment
- age
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
Signature 2
Source: Supp fig 2c and 2d
Description: Sex-related differences of the conjunctival microbiota in patients with dry eye.
Abundance in Group 1: decreased abundance in male patients with dry eye disease
NCBI | Quality Control | Links |
---|---|---|
Deinococcus sp. NW-56 | ||
Pseudomonas aeruginosa |
Revision editor(s): Mary Bearkland, ChiomaBlessing
Experiment 2
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Healthy female
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Healthy male
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Healthy male without dry eye disease
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- increased
Signature 1
Source: Supp fig 2c and 2d, Figure 3D
Description: Sex-related differences of the conjunctival microbiota in healthy individuals.
Abundance in Group 1: increased abundance in Healthy male
NCBI | Quality Control | Links |
---|---|---|
Pseudomonas aeruginosa | ||
Malassezia globosa |
Revision editor(s): Mary Bearkland, ChiomaBlessing
Experiment 3
Subjects
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Dry eye syndrome dry eye,Dry Eye Syndrome,dry eye syndrome,Dry Eye Syndromes,dry eye(s),eye(s), dry,KCS,Keraconjunctivitis sicca,Keratoconjunctivitis Sicca,Keratoconjunctivitis sicca,keratoconjunctivitis sicca,Keratoconjunctivitis sicca (disorder),sicca, keratoconjunctivitis,Tear film insufficiency,tear film insufficiency,Dry eye syndrome
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Aqueous tear deficient (ATD) DED
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Meibomian Gland Dysfunction (MGD) DED
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients with MGD DED
- Group 0 sample size Number of subjects in the control (unexposed) group
- 14
- Group 1 sample size Number of subjects in the case (exposed) group
- 19
- Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
- 90 days prior to study enrollment
Lab analysis
Statistical Analysis
- Statistical test
- Mann-Whitney (Wilcoxon)
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.15
- Confounders controlled for Confounding factors that have been accounted for by stratification or model adjustment
- age, sex
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
Signature 1
Source: Supp. fig 5
Description: Differentially abundant Staphylococcus species between patients with aqueous tear deficiency (ATD) and meibomian gland dysfunction (MGD)
Abundance in Group 1: increased abundance in Meibomian Gland Dysfunction (MGD) DED
NCBI | Quality Control | Links |
---|---|---|
Staphylococcus aureus | ||
Staphylococcus capitis |
Revision editor(s): Mary Bearkland, ChiomaBlessing
Signature 2
Source: Supp. fig 5
Description: Differentially abundant Staphylococcus species between patients with aqueous tear deficiency (ATD) and meibomian gland dysfunction (MGD)
Abundance in Group 1: decreased abundance in Meibomian Gland Dysfunction (MGD) DED
NCBI | Quality Control | Links |
---|---|---|
Staphylococcus hominis |
Revision editor(s): Mary Bearkland, ChiomaBlessing
Experiment 4
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Mixed DED
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients with mixed type diagnosis of DED (more closely related to MGD than ATD)
- Group 1 sample size Number of subjects in the case (exposed) group
- 35
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- increased
Signature 1
Source: Supp fig 5
Description: Differentially abundant Staphylococcus species between patients with aqueous tear deficiency (ATD) and mixed dry eye
Abundance in Group 1: increased abundance in Mixed DED
NCBI | Quality Control | Links |
---|---|---|
Staphylococcus aureus | ||
Staphylococcus capitis | ||
Staphylococcus cohnii |
Revision editor(s): Mary Bearkland, ChiomaBlessing
Experiment 5
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Meibomian Gland Dysfunction (MGD) DED
- Group 0 sample size Number of subjects in the control (unexposed) group
- 19
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
Experiment 6
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- healthy controls
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Dry Eye
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients with Dry eye disease
- Group 0 sample size Number of subjects in the control (unexposed) group
- 48
- Group 1 sample size Number of subjects in the case (exposed) group
- 47
Lab analysis
Statistical Analysis
- Statistical test
- MaAsLin2
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- decreased
Signature 1
Source: Supp table 4
Description: Comparison between dry eye group and healthy group showing species with polarized abundance (decreased abundance) in dry eye samples
Abundance in Group 1: increased abundance in Dry Eye
Revision editor(s): Mary Bearkland, ChiomaBlessing
Experiment 7
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Dry Eye -nonATD
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Dry Eye- ATD
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients with Dry eye disease characterized as aqueous tear deficient
- Group 0 sample size Number of subjects in the control (unexposed) group
- 54
- Group 1 sample size Number of subjects in the case (exposed) group
- 14
Lab analysis
Statistical Analysis
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.1
Signature 1
Source: Figure 4b
Description: B) Model coefficients of top-ranked species associated with either ATD or non-ATD dry eye (p < 0.1, coefficient >0.2)
Abundance in Group 1: increased abundance in Dry Eye- ATD
NCBI | Quality Control | Links |
---|---|---|
Janibacter melonis |
Revision editor(s): Mary Bearkland
Signature 2
Source: Figure 4b
Description: Figure 4b) Model coefficients of top-ranked species associated with either ATD or non-ATD dry eye (p < 0.1, coefficient >0.2) (
Abundance in Group 1: decreased abundance in Dry Eye- ATD
NCBI | Quality Control | Links |
---|---|---|
Capnocytophaga gingivalis |
Revision editor(s): Mary Bearkland
Experiment 8
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Dry Eye -nonMGD
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Dry Eye- MGD
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Patients with Dry eye disease characterized as meibomian gland disorder
- Group 0 sample size Number of subjects in the control (unexposed) group
- 49
- Group 1 sample size Number of subjects in the case (exposed) group
- 19
Lab analysis
Statistical Analysis
Signature 1
Source: Figure 4c
Description: Model coefficients of top-ranked species associated with either MGD or non-MGD dry eye (p < 0.1, coefficient >0.2)
Abundance in Group 1: increased abundance in Dry Eye- MGD
NCBI | Quality Control | Links |
---|---|---|
Acinetobacter sp. WCHA45 | ||
Deinococcus sp. NW-56 | ||
Staphylococcus aureus | ||
Staphylococcus capitis | ||
Staphylococcus cohnii |
Revision editor(s): Mary Bearkland
Signature 2
Source: Figure 4c
Description: Model coefficients of top-ranked species associated with either MGD or non-MGD dry eye (p < 0.1, coefficient >0.2)
Abundance in Group 1: decreased abundance in Dry Eye- MGD
NCBI | Quality Control | Links |
---|---|---|
Collinsella aerofaciens |
Revision editor(s): Mary Bearkland